Bliss GVS Pharma Limited Recommended Final Dividend of 50% i.e. 50 Paisa per equity share on the face value of INR 1/- each for the financial year ended March 31, 2024, subject to the approval of the shareholders in the forthcoming 39th Annual General Meeting of the Company (`39th AGM').
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
110.6 INR | +0.96% | +0.73% | -11.24% |
1st Jan change | Capi. | |
---|---|---|
-11.24% | 138M | |
+21.43% | 44.11B | |
+23.03% | 22.71B | |
+18.22% | 15.15B | |
+12.57% | 13.56B | |
+60.18% | 12.7B | |
-10.02% | 6.84B | |
-0.05% | 6.79B | |
-8.87% | 5.73B | |
+12.92% | 5.63B |
- Stock Market
- Equities
- BLISSGVS Stock
- News Bliss GVS Pharma Limited
- Bliss GVS Pharma Limited Recommends Final Dividend for the Financial Year Ended March 31, 2024